Boston Scientific Tries To Invalidate Wall Stent Patent

Law360, New York (August 08, 2008, 12:00 AM ET) -- Less than two weeks after inventor W. Henry Wall targeted Abbott Laboratories with claims that the company’s cardiovascular stents infringe his patent, Boston Scientific Corp. has filed a suit seeking to declare Wall's patent invalid, alleging the inventor withheld information from the U.S. Patent and Trademark Office while prosecuting his patent.

Boston Scientific, along with subsidiary Boston Scientific Scimed Inc., filed a complaint Wednesday in the U.S. District Court for the District of Delaware against patent holding company Wall Cardiovascular Technology LLC.

The suit asks the...
To view the full article, register now.